ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 92 filers reported holding ADMA BIOLOGICS INC in Q1 2020. The put-call ratio across all filers is 1.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $265,220 | -56.3% | 80,127 | -81.4% | 0.00% | – |
| Q4 2021 | $607,000 | +77.5% | 430,548 | +42.2% | 0.00% | – |
| Q3 2021 | $342,000 | -42.4% | 302,743 | -18.5% | 0.00% | -100.0% |
| Q2 2021 | $594,000 | +7.2% | 371,426 | +18.1% | 0.00% | 0.0% |
| Q1 2021 | $554,000 | +81.6% | 314,599 | +101.3% | 0.00% | 0.0% |
| Q4 2020 | $305,000 | +217.7% | 156,317 | +287.9% | 0.00% | – |
| Q3 2020 | $96,000 | +100.0% | 40,299 | +148.4% | 0.00% | – |
| Q2 2020 | $48,000 | -80.6% | 16,221 | -81.2% | 0.00% | -100.0% |
| Q1 2020 | $248,000 | -34.0% | 86,085 | -8.5% | 0.00% | -33.3% |
| Q4 2019 | $376,000 | +23.7% | 94,043 | +37.6% | 0.00% | +50.0% |
| Q3 2019 | $304,000 | +266.3% | 68,367 | +217.0% | 0.00% | +100.0% |
| Q2 2019 | $83,000 | +59.6% | 21,570 | +57.4% | 0.00% | 0.0% |
| Q1 2019 | $52,000 | +2500.0% | 13,700 | +1612.5% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 800 | -88.1% | 0.00% | – |
| Q3 2018 | $5,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |